AusBiotech is now inviting member submissions for the upcoming October 2025 edition of the Australasian Biotechnology journal — the sector’s long-standing platform for sharing insights, innovation, and expertise across the life sciences ecosystem.
Members are encouraged to submit a 200-word abstract highlighting their latest work or perspective. Topics may include:
- advanced therapies;
- capital raising;
- advanced manufacturing — global collaborations;
- clinical trials;
- patient engagement; and,
- emerging technologies.
This is a valuable opportunity to showcase your company or research to a national and international audience, connect with peers, and contribute to the conversation on life sciences innovation in Australia.
Australasian Biotechnology is AusBiotech’s official biannual journal, published in October and April. Written by the sector, for the sector, it highlights topics such as technology development, manufacturing excellence, sustainability, and strategies to strengthen Australia’s end-to-end life sciences value chain.
Renowned for its informed and authoritative editorials, the journal serves as an effective platform to reach stakeholders across the life sciences sector, including AusBiotech’s more than 3,000 members.
Readership spans companies, government bodies, universities, research institutes, biotechnology and medical technology organisations, and professional service providers in Australia and key international markets.
Abstracts should be 200 words and submitted to the Communications team at AusBiotech by 1 August 2025. Don’t miss your chance to be featured — submit your abstract today at communications@ausbiotech.org.